Tevfik Noyan

Tevfik Noyan

Auto-generated profile, based on publicly available information

Tevfik Noyan

Ordu University, School of Medicine

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2006 in Australian and New Zealand Journal of Obstetrics and Gynaecology
Verified
Journal Article
Closed access
PDF file
TNTevfik Noyan
Tevfik Noyan
AGAyşe GÜLER
Ayşe GÜLER
MŞMehmet Ramazan Şekeroğlu
Mehmet Ramazan Şekeroğlu
MKMansur Kamaci
Mansur Kamaci

1 January 2003 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
TNTevfik Noyan
Tevfik Noyan
IŞİdRis Şahın
İdRis Şahın
MŞM. Ramazan Şekeroğlu
M. Ramazan Şekeroğlu
HDHaluk Dülger
Haluk Dülger
Noyan T, et al. Yonsei Med J. 2003 Oct;44(5):771-778. http://dx.doi.org/10.3349/ymj.2003.44.5.771

29 September 2024 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
DADiler Us Altay
Diler Us Altay
YKYasemin Kaya
Yasemin Kaya
DDDuygu Mataraci Değirmenci
Duygu Mataraci Değirmenci
EKEmine Kocyigit
Emine Kocyigit
AÜAbdullah Üner
Abdullah Üner
TNTevfik Noyan
Tevfik Noyan
Background and Aim: Non‐alcoholic fatty liver disease (NAFLD) is characterized by the accumulation of excess fat in the liver, causing liver cell damage, increased inflammation, and weight gain. Despite its high prevalence, diagnosis and follow‐up of the disease is difficult. Irisin, a slimming myokine produced in response to physical activity (PA), exhibits anti‐inflammatory and anti‐obesity effects. This study aimed to investigate changes in irisin levels, inflammation markers (tumor necrosis factor‐α [TNF‐α] and interleukin‐6 [IL‐6]), and myeloid differentiation factor‐2 (MD2) levels in NAFLD, as well as anthropometric and routine biochemical parameters, by providing PA recommendations and nutrition education (NE) to individuals diagnosed with NAFLD over a period of 12 weeks. Methods: The study included 62 patients diagnosed with NAFLD who did not use alcohol. They were divided into groups: PA, NE, both (NE + PA), and untreated (control) patients. Patients receiving NE were provided with 1‐h NE sessions every 4 weeks for 12 weeks, and their personal information, nutritional status, 24‐h retrospective food consumption record, and anthropometric measurements were recorded at the beginning (day 0) and end (week 12) of the study. The PA group was recommended aerobic walking for 30 min, 5 days a week. At the beginning (day 0) and end (week 12) of the study, patients' anthropometric and routine biochemical tests were conducted, and irisin, MD2, TNF‐α, and IL‐6 levels were measured using the ELISA method. Results: All groups were similar in demographic characteristics and dietary habits. After 12 weeks, there were no significant differences in biochemical parameters among the groups. Glucose levels increased in the untreated group but decreased in the PA and PA + NE groups compared to baseline, with a significant decrease in the PA group. Insulin levels significantly decreased in the NE group. The PA + NE group showed decreased aspartate aminotransferase (AST), gamma‐glutamyl transferase, alkaline phosphatase, total cholesterol, low‐density lipoprotein, and triglyceride levels and significant decrease in ALT levels. AST decreased significantly in the PA group while high‐density lipoprotein increased significantly. There were no statistically significant differences between the groups in irisin, MD2, IL‐6, and TNF‐α levels. After 12 weeks, irisin levels significantly increased in nutrition and PA groups except the untreated group. There were no statistically significant differences in IL‐6 and MD2 levels compared with baseline after 12 weeks. PA recommendations alone were not effective in observing significant changes in anthropometric measurements in individuals with NAFLD. It was detected that only nutritional recommendations provided a significant decrease in body fat ratio but were insufficient for the change in other anthropometric measurements. In the group where NE and PA were recommended together, a significant decrease in anthropometric measurements was found. The NE group significantly reduced their energy and carbohydrates (%EI) intake after 12 weeks of intervention compared with the baseline. Conclusion: NE and PA recommendations led to improvements in liver‐related biochemical parameters and significant reductions in anthropometric measurements among individuals with NAFLD. Moreover, patients receiving NE experienced a decrease in energy and carbohydrates intake as a percentage of total energy intake (%EI). Increased irisin levels in NE, PA, and NE + PA groups may have contributed to the decrease in body fat percentage.

10 August 2022 in Archives of Dermatological Research
Verified
Journal Article
Closed access
PDF file
DADiler Us Altay
Diler Us Altay
SOSevda Onder
Sevda Onder
FEFatma Etgu
Fatma Etgu
AUAbdullah Uner
Abdullah Uner
TNTevfik Noyan
Tevfik Noyan

1 January 2009 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
TNTevfik Noyan
Tevfik Noyan
HGHüseyin Guducuoglu
Hüseyin Guducuoglu
MIMahmut Ilhan
Mahmut Ilhan
Noyan T, et al. Yonsei Med J. 2009 Oct;50(5):677-682. http://dx.doi.org/10.3349/ymj.2009.50.5.677

1 January 2004 in Renal Failure
Verified
Journal Article
Closed access
ISIdris Sahin
Idris Sahin
TNTevfik Noyan
Tevfik Noyan
EKEce Karaman
Ece Karaman
AYAhmet Sadık Yalçınkaya
Ahmet Sadık Yalçınkaya
AMAhmet Metin
Ahmet Metin
M.M.D.
M.D.
Aim: The aim of this study is to investigate the frequency of microalbuminuria and abnormal urinary beta2‐microglobulin excretion in patients with Behçet's disease (BD). Materials and Methods: Twenty‐eight patients and 27 healthy controls were included in this study. Urine albumin/creatinine and beta2‐microglobulin/creatinine ratios were calculated. Results: The frequency of microalbuminuria and abnormal urinary beta2‐microglobulin excretion was higher among patients with BD than in control group, but this was not statistically significant (p > 0.05). Conclusion: Microalbuminuria and abnormal beta2‐microglobulin excretion are markers of renal injury, which have not been investigated in BD previously. Renal injury in BD is more frequent than has been recognized and it is most often in mild nature.